This move is archived. Current quotes and coverage live on the stock page.
Get LABS alerts:
Medipharm Labs Corp's stock is on the rise, gaining over 7% in just one trading day, fueled by positive industry developments and strategic growth initiatives.
In the latest trading session, Medipharm Labs Corp (LABS.TO) saw its stock price surge by 7.14%, closing at CA$0.07. This upward momentum comes from several factors that position the company well in the evolving cannabis market.
Advertisement
Medipharm Labs Corp
LABS.TO
LABS.TO
Medipharm Labs Corp
WealthAwesomeMarket cap
$32.04M
52W high
$0.10
52W low
$0.06
1W change
+0.00%
Beta
0.93
Analyst Price Targets
Based on analyst covering LABS · as of Sep 17, 2026
Wall Street analysts forecast LABS stock price to rise 33.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.10
+33.3% Upside
Current Price
C$0.07
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LABS's historical volatility
30-Day Vol
58.3%
Annualized
90-Day Vol
74.6%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.07
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.06 – C$0.09 |
| 60 trading days | C$0.07 | C$0.05 – C$0.09 |
| 90 trading days | C$0.07 | C$0.05 – C$0.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Keep an eye on Medipharm Labs as it takes advantage of recent regulatory changes and expands internationally, which could lead to sustained growth.
Medipharm Labs Corp Surges 7.14% in One Day
With a market cap of CA$29.74 million, Medipharm Labs is navigating a challenging environment but is showing signs of resilience and potential growth.
Bull case
The recent U.S. government decision to reclassify cannabis could open up significant growth opportunities for Medipharm Labs. The company has already secured its FDA site registration and has experience supplying clinical trial materials, putting it in a strong position to benefit from these changes.
Bear case
Despite the positive momentum, investors should be cautious about the company’s ongoing struggle with profitability, as reflected in its negative profit margin of -20.21%.
Positive Industry Developments
Advertisement
The cannabis industry is undergoing a transformative moment with the U.S. government's recent decision to reclassify cannabis. This pivotal change could greatly enhance research and development opportunities for companies like Medipharm Labs, which is well-prepared to leverage its FDA site registration.
International Expansion Efforts
Medipharm Labs has made strides in international markets, recently completing its first shipment to France. This entry into the European market shows the company's commitment to expanding its global presence and meeting strict regulatory standards, which could drive future revenue growth.
Financial Position and Future Outlook
Despite a challenging profit margin, Medipharm Labs ended the last quarter with a solid cash position of CA$10.8 million and remains virtually debt-free. This financial stability provides a foundation for potential growth as the company navigates the evolving cannabis landscape.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
